Walmart Inc. and CVS Health Corp. said on Wednesday they would stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc. and Done Health.
https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersWalmart5-26-2022.webp7951200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-05-26 10:30:022022-05-26 11:28:27Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done
